BNR Brenntag SE
Brenntag SE distributes chemicals and ingredients in Germany, the United States, the United Kingdom, China, Canada, Italy, Poland, France, and internationally. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions, such as digital sales channels and product platforms. The company serves customers in various industries, including nutrition, pharma, beauty and care, and water treatment; and industrial markets, as well as coatings, adhesives, sealants and elastomers, and constructions, polymers, and rubber industries. The company was founded in 1874 and is headquartered in Essen, Germany.…
Industry Peers
Specialty ChemicalsKey Statistics
About Brenntag (ETR: BNR)
›
Brenntag (ETR: BNR) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 17,300 employees.
The shares were at 57.58 EUR on 19 November 2026, up 19.7% over 52 weeks. Its 52-week range is 43.72 EUR to 66.86 EUR: the price is 13.9% below the high and 31.7% above the low.
At a market capitalisation of 8.31B EUR, it trades at 21.9 times trailing earnings and 14.0 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a discount of 36% for BNR. It pays a dividend yielding 3.28% (it pays out 72% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Brenntag reports return on equity of 6.1%, an operating margin of 5.3% and revenue up 14.7% year over year.
Its debt exceeds its cash by 2.94B EUR, a debt-to-equity ratio of 0.76. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 15 analysts cover the stock, with an average rating of Hold; their mean price target of 59.20 EUR is 2.8% above the current price. The next earnings report is expected on 10 March 2027.